BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 231 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q2 2020. The put-call ratio across all filers is 0.22 and the average weighting 0.7%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $54,584,000 | +717.9% | 361,076 | +688.4% | 0.04% | +680.0% |
| Q2 2022 | $6,674,000 | +116.4% | 45,800 | +76.1% | 0.01% | +150.0% |
| Q1 2022 | $3,084,000 | -65.3% | 26,010 | -59.6% | 0.00% | -60.0% |
| Q4 2021 | $8,880,000 | +9.1% | 64,435 | +9.9% | 0.01% | 0.0% |
| Q3 2021 | $8,142,000 | +75.1% | 58,613 | +22.4% | 0.01% | +66.7% |
| Q2 2021 | $4,651,000 | +1.3% | 47,896 | -28.7% | 0.00% | 0.0% |
| Q1 2021 | $4,590,000 | +260.6% | 67,163 | +352.5% | 0.00% | +200.0% |
| Q4 2020 | $1,273,000 | +212.8% | 14,843 | +137.0% | 0.00% | – |
| Q3 2020 | $407,000 | -84.2% | 6,263 | -82.3% | 0.00% | -100.0% |
| Q2 2020 | $2,582,000 | +101.2% | 35,325 | -6.3% | 0.00% | +100.0% |
| Q1 2020 | $1,283,000 | -45.4% | 37,715 | -12.6% | 0.00% | -50.0% |
| Q4 2019 | $2,350,000 | +168.6% | 43,169 | +105.8% | 0.00% | +100.0% |
| Q3 2019 | $875,000 | -69.9% | 20,973 | -68.4% | 0.00% | -50.0% |
| Q2 2019 | $2,904,000 | +780.0% | 66,298 | +933.3% | 0.00% | – |
| Q1 2019 | $330,000 | -90.4% | 6,416 | -93.1% | 0.00% | -100.0% |
| Q4 2018 | $3,434,000 | +36.8% | 92,861 | +38.9% | 0.00% | +50.0% |
| Q3 2018 | $2,510,000 | +69.7% | 66,842 | +78.7% | 0.00% | +100.0% |
| Q2 2018 | $1,479,000 | +36875.0% | 37,406 | +22990.1% | 0.00% | – |
| Q1 2018 | $4,000 | -20.0% | 162 | -3.6% | 0.00% | – |
| Q4 2017 | $5,000 | +150.0% | 168 | +150.7% | 0.00% | – |
| Q2 2017 | $2,000 | – | 67 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 2,111,111 | $144,294,000 | 54.16% |
| Knoll Capital Management, LLC | 856,844 | $58,565,000 | 38.16% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,123,271 | $145,126,000 | 21.73% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 860,261 | $58,799,000 | 6.01% |
| ARS Investment Partners, LLC | 561,442 | $38,375,000 | 4.46% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $12,057,000 | 3.19% |
| Eventide Asset Management | 2,015,000 | $137,725,000 | 2.04% |
| Avidity Partners Management LP | 1,049,800 | $71,754,000 | 1.98% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 50,089 | $3,424,000 | 1.87% |
| Nicholas Investment Partners, LP | 375,654 | $25,676,000 | 1.79% |